TEM – tempus ai, inc. - class a (US:NASDAQ)

News

AI-Powered Tempus Inks New Multi-Year Merck Deal [Yahoo! Finance]
Tempus AI (TEM) had its price target lowered by Morgan Stanley from $85.00 to $70.00. They now have an "overweight" rating on the stock.
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
Tempus AI (TEM) was downgraded by Wall Street Zen from "hold" to "sell
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com